Ghofrani H, Simonneau G, D'Armini AM, et al. Efficacy and Safety of Macitentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from the Randomized Controlled MERIT Study. ATS 2017, A7601.
Selexipag verbetert hemodynamiek, maar niet inspanningscapaciteit bij inoperabele CTEPH
jul 2022 | Pulmonale hypertensie